Abstract Applying toxic chemical to the synthesis of stable gold nanoparticles is one of the limitations of gold nanoparticles for therapeutic applications such as photothermal therapy. Plant compounds such as apigenin (API) with therapeutic potential can be applied in the synthesis of gold nanoparticles. API‐coated gold nanoparticles (Api@AuNPs) with an average size of 19.1 nm and a surface charge of −4.3 mV have been synthesized by a simple and efficient technique. The stability of Api@AuNPs in the biological environment was verified through UV‐Vis spectroscopy. Based on Raman and FTIR spectroscopy analysis, chemical binding of API on the surface of Api@AuNPs through hydroxyl and carbonyl functional groups was found to be the main reason ...
Background: In recent decades, gold nanoparticle (Au NP)-based cancer therapy has been heavily debat...
Gold nanoparticles (AuNP) obtained by laser ablation synthesis in liquid solution (LASiS) can be eas...
Rabiee, Navid/0000-0002-6945-8541WOS: 000527880400001PubMed: 32425523Background: The development of ...
Gold nanoparticles (AuNPs) have been introduced for increasing the effectiveness of various cancer t...
Chemo-resistance from cancer stem cells (CSCs) subpopulation is a current issue in cancer treatment....
In this investigation, the anticancer potentiality and biological mechanism of gold nanoparticles (A...
Introduction During the process photodynamic therapy (PDT), bleaching of photosensitizer induced by ...
M.Sc. (Nanoscience)Abstract: Globally, colorectal cancer (CRC) is one of the most prevalent cancer a...
Gold nanoparticles exhibit an array of properties, both intrinsic (chemical) and extrinsic (photothe...
Current cancer treatment options, including surgery, chemotherapy and radiation therapy, often cause...
Gold nanoparticles (AuNPs) have diverse applications in the diagnosis and treatment of ailments. Thi...
Nanotechnology, a frontier science and technology to construct a “small world”, will open a new para...
Colorectal cancer (CRC) is a widespread and lethal disease. Relapses of the disease and metastasis a...
Cancer is the second leading cause of death globally, and was estimated to account for 9.6 million d...
none11noColorectal cancer (CRC) is a widespread and lethal disease. Relapses of the disease and meta...
Background: In recent decades, gold nanoparticle (Au NP)-based cancer therapy has been heavily debat...
Gold nanoparticles (AuNP) obtained by laser ablation synthesis in liquid solution (LASiS) can be eas...
Rabiee, Navid/0000-0002-6945-8541WOS: 000527880400001PubMed: 32425523Background: The development of ...
Gold nanoparticles (AuNPs) have been introduced for increasing the effectiveness of various cancer t...
Chemo-resistance from cancer stem cells (CSCs) subpopulation is a current issue in cancer treatment....
In this investigation, the anticancer potentiality and biological mechanism of gold nanoparticles (A...
Introduction During the process photodynamic therapy (PDT), bleaching of photosensitizer induced by ...
M.Sc. (Nanoscience)Abstract: Globally, colorectal cancer (CRC) is one of the most prevalent cancer a...
Gold nanoparticles exhibit an array of properties, both intrinsic (chemical) and extrinsic (photothe...
Current cancer treatment options, including surgery, chemotherapy and radiation therapy, often cause...
Gold nanoparticles (AuNPs) have diverse applications in the diagnosis and treatment of ailments. Thi...
Nanotechnology, a frontier science and technology to construct a “small world”, will open a new para...
Colorectal cancer (CRC) is a widespread and lethal disease. Relapses of the disease and metastasis a...
Cancer is the second leading cause of death globally, and was estimated to account for 9.6 million d...
none11noColorectal cancer (CRC) is a widespread and lethal disease. Relapses of the disease and meta...
Background: In recent decades, gold nanoparticle (Au NP)-based cancer therapy has been heavily debat...
Gold nanoparticles (AuNP) obtained by laser ablation synthesis in liquid solution (LASiS) can be eas...
Rabiee, Navid/0000-0002-6945-8541WOS: 000527880400001PubMed: 32425523Background: The development of ...